Casdin Capital

Casdin Capital invests in all aspects of the life sciences revolution, partnering with companies across Healthcare, Biotechnology, Synthetic Biology, and Technology. Their investment strategy focuses on big markets, great ideas, strong teams, and a long-term perspective. They aim to create value and open new opportunities through patience and strong relationships.

Casdin Capital favicon
Founded 2012 ยท Venture Capital
Investment Stages
Series A
Series B
Series C
Markets
Healthcare
Biotechnology
Synthetic Biology
Technology
Portfolio Companies

23andMe, 4D Molecular Therapeutics, 908 devices, A2 Biotherapeutics, AbSci, Adaptive Biotechnologies, Affinia, Alector, Aledade, AmplifyBio

Share this page